Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Optimal prevention of CVD in patients with HIV includes attention to risk factors such as tobacco use, hyperlipidemia, hypertension, glucose abnormalities, obesity, family history of CVD, and metabolic syndrome
  • Patients should be educated about CVD risks using interventions directed at those factors that are modifiable and with referral to dietary support and exercise programs as needed
  • Smoking is a critical modifiable risk factor that should be addressed in patients with HIV[Petoumenos 2011]

Action required

Keywords: Cardiovascular Disease, Treatment Complications

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.